BBLOVE Blood Pressure Monitor, FSA-HSA Eligible, One-Touch Voice Control
Automatic - 产品分析报告
  • Benchmark ASIN
    B0FNRDR168
  • Marketplace
    US
  • Category ID
    21180956011
  • Analyzed Products
  • Keyword
    home health
  • Price Range
    -
  • Minimum Net Profit Margin
    10.00%
  • MOQ
    100
  • Est. Purchasing Cost
    ¥37.67estimated
  • Data Date
    2026-08-10
  • Your Budget (for new listing) (CNY)
    ¥500,000.00
Profitability Difficulty
Unknown
Unknown - Insufficient New Releases
Newly Released Counts (All Brands)
5
New Brand (1)
Old Brand (4)
Success rate (all brands)
40.00%
New Brand (100.00%)
Old Brand (25.00%)
Most products net profit margin range
34.83% - 38.40%
Listing

Report summary from Keble AI Agent: Listing

这个市场不值得进入,结论很明确:已出现老品牌主导、利润被压缩、且新机会主要被资源型玩家吃掉的格局。 现在不是适合小品牌试水的窗口;大品牌若要进,也只能靠明显功能升级和更高投入去硬打,但从当前数据看,回报并不漂亮。

Recommended Products Features Direction
B0DKF33SP2
Why do customers choose it?
  • 黑色大号6英寸彩色LED显示屏,视觉上更偏向高对比度和老年友好。
  • 双袖带配置(17英寸+21英寸)覆盖大臂人群,且机身采用大屏幕一体式智能血压计外观,与常见单袖带机型相比更有辨识度。
  • 支持蓝牙同步到免费APP,并可对接Apple Health和Google Fit;同时提供无登录、无个人信息输入的数据存储与CSV导出分享。
  • 主要面向大臂/肥胖人群、老年用户,以及需要家庭多人管理和远程分享血压数据的家庭健康管理场景。
  • Sales
    Avg. price: $48.93|Latest price: $48.99|Approx. recent monthly revenue: $48,930.00 (1000 pcs)|Net profit margin: 35.48%
    B0FNRDR168
    Why do customers choose it?
  • 浅蓝背光大屏,整体更偏家用舒适风格
  • 双屏并排对比当前与上一次测量结果,外观交互差异明显
  • 双屏同步显示新旧读数,方便快速观察血压趋势
  • 更适合需要家庭共用、夜间安静测量、并希望快速对比历史读数的家庭用户
  • Sales
    Avg. price: $62.79|Latest price: $34.29|Approx. recent monthly revenue: $25,116.00 (400 pcs)|Net profit margin: 39.10%

    These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.

    New Brands
    VS
    Old Brands
    1 new brands5 old brands
    1 brands have new listings3 brands have new listings
    1 new listings4 new listings
    1 succeeded
    1 succeeded
    0 failed
    2 failed

    Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.

    New Brands
    Old Brands
    ...

      How much did others invest?

      Collapse
    • #Budget Requirement

      Listing

      结论很明确:这个市场不值得现在进入。 当前样本里新品牌/老品牌都在靠差异化和品牌力吃饭,但新品利润并不差,真正的问题是你只有50万CNY,能覆盖入场的第一段成本,却很难覆盖后续品牌、研发和认证投入;同时市场里旧品牌占了新产品的80%,说明竞争入口主要被成熟玩家和老资源控制。

      Early sourcing + logistics + marketing budget (USD)
      N/A
      Explains the budget

      With all these investments, who has profitable new releases

      How many new listings are released by old brands?
      80.00%
      New listing success rate (old brands):
      25.00%
      New listing success rate (new brands):
      100.00%
      Which new brands have these successful new listings?
      Which old brands have these successful new listings?
      Potential certificate expenses
      UL Certification
      FCC Certification

      Some categories may not originally require certain certificates for entry; however, some products may target specific features (e.g. Bluetooth) or customers (e.g. children), and additional certificates may be required in the target marketplace (e.g. FCC, CPC).

      Alternatives
      1. 租用或借用家用上臂式血压计:如果只是短期监测(如术后、孕期、换药/复诊前),比购买更省钱,也更容易先验证是否真的需要长期自测。
      2. 去药房/社区诊所做定期免费或低价血压测量:对不想承担设备费用、又只需要阶段性记录的人,这是最直接的替代方案。
      3. 使用家庭成员共用的基础款自动血压计:若家里已有普通血压计,可直接复用,不必为双人记忆、语音控制、双屏等附加功能付费。
      4. 选择手机/小程序记录配合手动测量:用更便宜的基础血压计加电子表格/健康App记录,替代带存储、双用户、趋势比较的高价型号。
      5. 购买基础无语音、无双屏的入门自动血压计:如果用户只需要“量出数值”,这类更便宜、更易买到,且通常操作更简单。
      6. 选择腕式血压计作为低门槛替代:在某些场景下更便携、体积更小,适合出行或空间有限的用户;虽然准确性和姿势要求要注意,但作为低成本替代常被考虑。
      7. 使用医生随访+家庭测量的混合方案:把血压管理交给门诊复诊和少量家庭测量,减少对高规格家用设备的依赖。

      Alternative solutions may pose a risk to your investment in certain markets.

    • #Brands Investment Analysis

      Listing

      这个市场不建议进入:利润看起来高,但已经出现明显的价格战和头部品牌挤压迹象,小品牌更不该硬闯。 目前样本里可确认的可盈利产品占 66.67%,但新上架产品里只有 40% 盈利;同时过去一年新上架里,老品牌占到 80%,说明新机会主要被有资源的老牌吃掉了。

      BBLOVE
      Most investment in new productsNew products with Highest revenueLeast investment in new products
      BBLOVE Blood Pressure Monitor, FSA-HSA Eligible, One-Touch Voice Control
      Recent Monthly Revenue (USD):$25,116.00(400pcs/month)
      B0FNRDR168 (4.2/5 (268 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
      Andesfit
      Old brand with the most profitable new products
      Andesfit Upper Arm Blood Pressure Monitor for Home Use 17" Large & 21" XL Extra Large Cuff Big arm, Free APP Bluetooth Sync Apple Health Track Google Fit, Large Display Smart BP Machine for Seniors
      Recent Monthly Revenue (USD):$48,930.00(1000pcs/month)
      B0DKF33SP2 (4.3/5 (727 Reviews))Brand is an old entry in this market
      Old ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
    • #Differentiations

      Unique productsCommon products
      Andesfit Upper Arm Blood Pressure Monitor for Home Use 17" Large & 21" XL Extra Large Cuff Big arm, Free APP Bluetooth Sync Apple Health Track Google Fit, Large Display Smart BP Machine for Seniors
      Differentiation:
      1. 6英寸大彩屏,字号大,老年人一眼可见
      2. 黑色高对比机身,和常见机型差异明显
      3. 双袖带配置更实用,吸引大臂用户和家庭用户
      B0DKF33SP2 (4.3/5 (727 Reviews))Brand is an old entry in this market
      Old ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
      BBLOVE Blood Pressure Monitor, FSA-HSA Eligible, One-Touch Voice Control
      Differentiation:
      1. 双屏并排显示新旧读数,画面很容易吸引点击
      2. 浅蓝背光风格更柔和,家用感更强
      3. 一键静音+双用户切换,适合家庭共用场景
      B0FNRDR168 (4.2/5 (268 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
    • What net profit margin are others making?

      Collapse
    • #Net Profit Margins: All vs New

      Listing

      这个市场不适合现在进入,结论是:不建议做。 这不是健康增长盘,而是被老品牌主导、靠差异化和品牌力硬撑利润的市场;新品牌里虽然有成功案例,但数量太少,且成功主要集中在少数老品牌新上新。

      Profitability difficulty
      Unknown - Insufficient New Releases

      All products distribution on different profit levels

      All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other

      New products distribution on different profit levels

      This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other
    • #Top Products by Net Profit Margin

      Top 20 Profitable Products

      Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.

      B0DKF33SP2
      B0DKF33SP2
      Andesfit
      2024-10-21
      Yes
      $48.93
      1000pcs
      $48930.0
      35.48%
      $17360.37
      B0FNRDR168
      B0FNRDR168
      BBLOVE
      2025-09-19
      Yes
      $62.79
      400pcs
      $25116.0
      39.1%
      $9820.36
      B0H3P74MT9
      B0H3P74MT9
      VOLUETH
      2026-06-02
      Yes
      $49.99
      100pcs
      $4999.0
      36.78%
      $1838.64
      B0D9Y91L76
      B0D9Y91L76
      VOLUETH
      2024-07-23
      Yes
      $49.99
      100pcs
      $4999.0
      36.66%
      $1832.64
      B01B4PKQL2
      B01B4PKQL2
      Beurer
      2022-08-26
      Yes
      $34.49
      100pcs
      $3449.0
      33.33%
      $1149.56
      B0DSQ7Y77N
      B0DSQ7Y77N
      Homedics
      2025-01-10
      Yes
      $57.36
      50pcs
      $2868.0
      38.62%
      $1107.63

      Top 20 Profitable New Products

      Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.

      B0FNRDR168
      B0FNRDR168
      BBLOVE
      2025-09-19
      Yes
      $62.79
      400pcs
      $25116.0
      39.1%
      $9820.36
      B0H3P74MT9
      B0H3P74MT9
      VOLUETH
      2026-06-02
      Yes
      $49.99
      100pcs
      $4999.0
      36.78%
      $1838.64
    • Is this a good time to enter the market?

      Collapse
    • #New Product Success Rates

      Listing

      这个市场不建议进入:新品成功率低、旧品牌主导明显,而且已经出现明显的价格/利润挤压信号。 当前样本里可识别的新品只有4个,盈利2个、亏损2个,表面成功率50%,但真正新品牌里只有 BBLOVE 1 个成功案例;老品牌新品成功率仅25%,说明进入门槛主要靠品牌力、差异化和更高的前期投入,不是普通小卖家能轻松复制的。

      New products success rate.

      What is the ratio of profitable products

      Profitable (Unidentifiable released date)
      Profitable (Old product)
      Profitable (New product)
      Profitable (New product on old listing)
      New products but non profitable

      Profitable new products divide by brands

      What is the ratio of different brands owning all profitable new products

      VOLUETH
      BBLOVE

      Nonprofitable new products divide by brands

      What is the ratio of different brands owning all nonprofitable new products

      VOLUETH
      Beurer
    • #Success Rate by Entry Time

      Listing

      结论很明确:这个市场目前不适合进入,至少不适合中小卖家,也不值得大品牌重仓。 近一年几乎只看到少量新品牌在试水,且新增里已经出现利润下滑和亏损案例,说明竞争在变硬、不是在变松;更关键的是,当前可见的成功样本太少,根本撑不起“可复制的低风险机会”。

      从时间走势看,2022-2024几乎没有新增可见样本,2025开始才出现零星进入,2026年新增明显变多,但结果是1个盈利、2个亏损、1个结果不明;这不是健康增长,而是进入人数上升、利润表现分化、亏损占比抬头。按现有样本看,新品牌里只有 BBLOVE 的 B0FNRDR168 明确跑通:39.1%利润率、近月销售400、近月营收25116美元、早期投入约10389美元,属于真实可复制的白帽新品牌成功案例;但同一时间,Beurer 的 B0H2G8S148、VOLUETH 的 B0H6QMKBTY 都落入非盈利,说明新进入者并没有形成稳定普遍胜率。更要注意的是,这个市场里看不到30+新品牌同时涌入的“彻底过热”信号,但当前样本已经出现利润竞争加剧的苗头;如果后续继续加速,风险会很快上升。

      How many products released each year

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

      How many products released each month

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

    • #Net Profit Margins by Entry Time

      Different profit ratios of products released in year

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      202200000000
      202300000000
      202400000000
      202500000100
      202600000103
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable

      Different profit ratios of products released in month

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      2025/800000000
      2025/900000100
      2025/1000000000
      2025/1100000000
      2025/1200000000
      2026/100000000
      2026/200000000
      2026/300000000
      2026/400000000
      2026/500000001
      2026/600000101
      2026/700000000
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable
    • What factors contribute to success or failure?

      Collapse
    • #Case Study

      Success Cases
      Beurer BM27 Upper Arm Blood Pressure Monitor for Home Use with Adjustable Cuff, 120 Memory Sets, Irregular Heart Rate Detection, Risk Indicator, Data Transfer to Apple Health and co.
      Price (USD)
      $34.49
      Released Type
      Old Release (2022-08-26)
      Brand is an old entry in this market
      Size and Weight
      15.9 x 12.2 x 9.0 cm, 588.00g

      Profitable Factors

      Established brand with longevityBased on old ASIN

      Key Buying Motive

      支持免费应用同步到 Apple Health / Samsung Health / Health Connect,便于长期记录和导出管理

      Target Customers

      适合注重品牌可信度、希望把家庭血压记录统一到手机健康生态中的家庭用户和中老年用户

      Early Investment

      Investment

      Monthly Revenue (Recent) (USD)
      $3,449.00
      100 sold in the past 30 days · as of 2026年8月

      Net Profit Margin

      Sea Freight
      31.56% / 33.33%
      Peak / Non Peak
      Rail Freight
      - / -
      Peak / Non Peak
      Air Freight
      23.23% / 25.00%
      Peak / Non Peak

      Sales & BSR Performance

      VOLUETH Blood Pressure Monitor for Home Use - 3 Size Cuffs, Small 6"-10", Medium/Large 9"-17" and Extra Large 13"-24", Perfect for Family Health Monitoring
      Price (USD)
      $49.99
      Released Type
      Old Release (2024-07-23)
      Brand is an old entry in this market
      Size and Weight
      17.7 x 13.4 x 9.3 cm, 667.00g

      Profitable Factors

      Based on old ASIN

      Design & Appearance

      三种袖带组合覆盖更宽的臂围范围,包含适合大臂的超大袖带

      Key Buying Motive

      同类产品里更突出的是一次性配齐三种袖带,减少用户额外购买配件的需求,并提升家庭多人共用的适配性

      Target Customers

      需要一家多人共用、且包含大臂/特殊臂围人群的家庭健康监测用户

      Early Investment

      Investment

      Monthly Revenue (Recent) (USD)
      $4,999.00
      100 sold in the past 30 days · as of 2026年8月

      Net Profit Margin

      Sea Freight
      35.28% / 36.66%
      Peak / Non Peak
      Rail Freight
      - / -
      Peak / Non Peak
      Air Freight
      28.75% / 30.13%
      Peak / Non Peak

      Sales & BSR Performance

      Loading samples... 33%
    What is Keble?

    Keble is an e-commerce AI Agent that helps sellers solve daily e-commerce issues. This report is generated by Keble AI.

    Analyze Product Opportunity with Keble
    1. One report to tell you whether to enter the market or not, significantly reducing inventory risk.
    Keble AI Agent